Wang LZ, Wang KP, Mo JG, Wang GY, Jin C, Jiang H, Feng YF. Minimally invasive treatment of hepatic hemangioma by transcatheter arterial embolization combined with microwave ablation: A case report. World J Clin Cases 2021; 9(24): 7154-7162 [PMID: 34540972 DOI: 10.12998/wjcc.v9.i24.7154]
Corresponding Author of This Article
Yi-Fu Feng, MD, Doctor, Department of Hepatobiliary Surgery, Taizhou Central Hospital (Affiliated Hospital of Taizhou University), No. 999 Donghai Avenue, Jiaojiang District, Taizhou 510000, Zhejiang Province, China. fengyf9614@tzzxyy.com
Research Domain of This Article
Surgery
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Lie-Zhi Wang, Kun-Peng Wang, Jing-Gang Mo, Chong Jin, Hao Jiang, Department of General Surgery, Taizhou Central Hospital (Taizhou University Hospital), Taizhou 318000, Zhejiang Province, China
Guo-Yu Wang, Department of Radiology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou 318000, Zhejiang Province, China
Yi-Fu Feng, Department of Hepatobiliary Surgery, Taizhou Central Hospital (Affiliated Hospital of Taizhou University), Taizhou 510000, Zhejiang Province, China
Author contributions: Wang LZ and Wang KP contributed equally to this work; Wang LZ and Wang KP designed this study and wrote the manuscript; Feng YF and Mo JG collected the patient’s clinical date; Wang GY and Jiang H carried out the TAE treatment; Jiang H and Jin C carried out the microwave ablation; Wang LZ and Feng YF revised the manuscript; all authors read and approved the final manuscript.
Supported byZhejiang Province Public Welfare Technology Application Research Project, No. LGF21H160022; Project of Taizhou University, No. 2018PY057; Project of Taizhou Central Hospital, No. 2019KT003; Taizhou Social Development Science and Technology Plan Project, No. 21ywb26 and No. 21ywb29.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare they have no conflict of interest to report.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yi-Fu Feng, MD, Doctor, Department of Hepatobiliary Surgery, Taizhou Central Hospital (Affiliated Hospital of Taizhou University), No. 999 Donghai Avenue, Jiaojiang District, Taizhou 510000, Zhejiang Province, China. fengyf9614@tzzxyy.com
Received: January 6, 2021 Peer-review started: January 6, 2021 First decision: July 5, 2021 Revised: July 7, 2021 Accepted: July 14, 2021 Article in press: July 14, 2021 Published online: August 26, 2021
Abstract
BACKGROUND
Hepatic hemangioma is the most common benign tumor of the liver. However, patients with large hemangiomas that cause compression symptoms or that are at risk of rupture may need further intervention. It is necessary to explore additional minimally invasive and personalized treatment options for hemangiomas.
CASE SUMMARY
A 47-year-old woman was diagnosed with a right hepatic hemangioma for more than 10 years. Abdominal contrast-enhanced computed tomography (CT) and contrast-enhanced ultrasound revealed that there was a large hemangioma in the right liver, with a size of approximately 95 mm × 97 mm × 117 mm. Due to the patient's refusal of surgical treatment, hepatic artery embolization was performed in the first stage. After 25 d of liver protection treatment, the liver function indexes decreased to normal levels. Then, ultrasound-guided microwave ablation of the giant hepatic hemangioma was performed. Ten days after the treatment, hepatobiliary ultrasonography showed that the hemangioma of the right liver was smaller than the previous size (the volume was reduced by approximately 30%). Then the patient was discharged from the hospital. One year after discharge, CT showed that the hepatic hemangioma had shrunk by about 80%
CONCLUSION
Transcatheter arterial embolization combined with microwave ablation is a safe and effective minimally invasive treatment for hepatic hemangioma.
Core Tip: Hepatic hemangioma is the most common benign tumor of the liver. However, patients with large hemangiomas that cause compression symptoms or that are at risk of rupture may need further intervention. It is necessary to explore additional minimally invasive and personalized treatment options for hemangiomas. Here, we present the case of a 47-year-old woman who was diagnosed with a right hepatic hemangioma for more than 10 years. Abdominal contrast-enhanced computed tomography and contrast-enhanced ultrasound revealed that there was a large hemangioma in the right liver, with a size of approximately 95 mm × 97 mm × 117 mm. Hepatic artery embolization was performed in the first stage. Then, ultrasound-guided microwave ablation of the giant hepatic hemangioma was performed.
